AKR1B10 Expression in Gastric Cancer and Its Role in Tumor Microenvironment
Author Information
Author(s): Wu Anqi, Li Hao, Gao Mengnan, Liang Juan, Huang Jiaqi, Farrés Jaume, Cao Deliang, Li Guoqing
Primary Institution: The Second Affiliated Hospital, Hengyang Medical School, University of South China
Hypothesis
The study investigates the expression pattern and role of AKR1B10 in various cancers, particularly gastric cancer.
Conclusion
AKR1B10 expression is significantly diminished in gastric cancer, which may influence immune cell infiltration and tumor progression.
Supporting Evidence
- AKR1B10 is highly expressed in healthy gastrointestinal tissues but significantly altered in various cancers.
- Lower AKR1B10 expression in gastric cancer correlates with increased CD68+ macrophages and decreased CD19+ B cells.
- AKR1B10 may serve as a potential therapeutic target in multiple cancers.
Takeaway
This study found that a protein called AKR1B10 is lower in stomach cancer, which might affect how the immune system interacts with the cancer.
Methodology
The study analyzed RNA sequencing data from 33 cancer types and evaluated AKR1B10 expression using various bioinformatics tools and immunofluorescence staining.
Limitations
The study primarily focuses on AKR1B10's role in gastric cancer and may not fully address its implications in other cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website